Neurocrine Biosciences, Inc. (LON:0K6R)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,470	11,039	10,163	9,530	5,967	6,559
Market Cap Growth	15.68%	8.62%	6.65%	59.70%	-9.03%	-12.25%
Enterprise Value	9,987	10,287	9,518	9,101	5,736	6,246
Last Close Price	104.66	108.92	104.04	98.59	63.33	70.46
PE Ratio	32.88	40.49	51.85	74.32	90.18	21.99
PS Ratio	5.25	5.87	6.86	7.71	7.13	8.56
PB Ratio	4.69	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	4.74	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	23.73	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	22.10	23.21	33.20	33.83	31.50	39.19
EV/Sales Ratio	4.89	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	20.79	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	24.30	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	22.63	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.16	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.81	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.69	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	17.15	15.99	16.48	14.85	11.71	12.59
Quick Ratio	2.89	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.38	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.96%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	8.66%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Capital (ROIC)	10.41%	12.68%	10.66%	8.22%	7.75%	15.33%
Return on Capital Employed (ROCE)	14.90%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	3.04%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	4.21%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	1.30%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.